These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of Pseudomonas lytic phages and their application as a cocktail with antibiotics in controlling Pseudomonas aeruginosa. Ong SP; Azam AH; Sasahara T; Miyanaga K; Tanji Y J Biosci Bioeng; 2020 Jun; 129(6):693-699. PubMed ID: 32107153 [TBL] [Abstract][Full Text] [Related]
3. Analyses of Short-Term Antagonistic Evolution of Pseudomonas aeruginosa Strain PAO1 and Phage KPP22 (Myoviridae Family, PB1-Like Virus Genus). Uchiyama J; Suzuki M; Nishifuji K; Kato SI; Miyata R; Nasukawa T; Yamaguchi K; Takemura-Uchiyama I; Ujihara T; Shimakura H; Murakami H; Okamoto N; Sakaguchi Y; Shibayama K; Sakaguchi M; Matsuzaki S Appl Environ Microbiol; 2016 Aug; 82(15):4482-4491. PubMed ID: 27208109 [TBL] [Abstract][Full Text] [Related]
4. Phage steering of antibiotic-resistance evolution in the bacterial pathogen, Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028 [TBL] [Abstract][Full Text] [Related]
5. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice. Vinodkumar CS; Kalsurmath S; Neelagund YF Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958 [TBL] [Abstract][Full Text] [Related]
6. Resistance against two lytic phage variants attenuates virulence and antibiotic resistance in García-Cruz JC; Rebollar-Juarez X; Limones-Martinez A; Santos-Lopez CS; Toya S; Maeda T; Ceapă CD; Blasco L; Tomás M; Díaz-Velásquez CE; Vaca-Paniagua F; Díaz-Guerrero M; Cazares D; Cazares A; Hernández-Durán M; López-Jácome LE; Franco-Cendejas R; Husain FM; Khan A; Arshad M; Morales-Espinosa R; Fernández-Presas AM; Cadet F; Wood TK; García-Contreras R Front Cell Infect Microbiol; 2023; 13():1280265. PubMed ID: 38298921 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1-like phages. Fujiki J; Furusawa T; Munby M; Kawaguchi C; Matsuda Y; Shiokura Y; Nakamura K; Nakamura T; Sasaki M; Usui M; Iwasaki T; Gondaira S; Higuchi H; Sawa H; Tamura Y; Iwano H Microbiol Immunol; 2020 Nov; 64(11):778-782. PubMed ID: 32918505 [TBL] [Abstract][Full Text] [Related]
8. Preclinical Development of a Bacteriophage Cocktail for Treating Multidrug Resistant Camens S; Liu S; Hon K; Bouras GS; Psaltis AJ; Wormald PJ; Vreugde S Microorganisms; 2021 Sep; 9(9):. PubMed ID: 34576896 [TBL] [Abstract][Full Text] [Related]
9. Phage Morons Play an Important Role in Pseudomonas aeruginosa Phenotypes. Tsao YF; Taylor VL; Kala S; Bondy-Denomy J; Khan AN; Bona D; Cattoir V; Lory S; Davidson AR; Maxwell KL J Bacteriol; 2018 Nov; 200(22):. PubMed ID: 30150232 [TBL] [Abstract][Full Text] [Related]
10. Evolution of Pseudomonas aeruginosa virulence as a result of phage predation. Hosseinidoust Z; van de Ven TG; Tufenkji N Appl Environ Microbiol; 2013 Oct; 79(19):6110-6. PubMed ID: 23892756 [TBL] [Abstract][Full Text] [Related]
11. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Reed E; Ding L; Gong J; Li QQ; Hu J Int J Mol Med; 2006 Feb; 17(2):309-17. PubMed ID: 16391831 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a bacteriophage with broad host range against strains of Pseudomonas aeruginosa isolated from domestic animals. de Melo ACC; da Mata Gomes A; Melo FL; Ardisson-Araújo DMP; de Vargas APC; Ely VL; Kitajima EW; Ribeiro BM; Wolff JLC BMC Microbiol; 2019 Jun; 19(1):134. PubMed ID: 31208333 [TBL] [Abstract][Full Text] [Related]
16. Development of a Bacteriophage Cocktail to Constrain the Emergence of Phage-Resistant Yang Y; Shen W; Zhong Q; Chen Q; He X; Baker JL; Xiong K; Jin X; Wang J; Hu F; Le S Front Microbiol; 2020; 11():327. PubMed ID: 32194532 [TBL] [Abstract][Full Text] [Related]
17. Isolation and Characterization of Lytic Bacteriophage Against Multi-drug Resistant Pseudomonas aeruginosa. Maharjan A; Nepal R; Dhungana G; Parajuli A; Regmi M; Upadhyaya E; Mandal D; Shrestha M; Pradhan P; Manandhar KD; Malla R J Nepal Health Res Counc; 2022 Mar; 19(4):717-724. PubMed ID: 35615828 [TBL] [Abstract][Full Text] [Related]
18. Inhaled bacteriophage therapy in a porcine model of pneumonia caused by Pseudomonas aeruginosa during mechanical ventilation. Guillon A; Pardessus J; L'Hostis G; Fevre C; Barc C; Dalloneau E; Jouan Y; Bodier-Montagutelli E; Perez Y; Thorey C; Mereghetti L; Cabrera M; Riou M; Vecellio L; Le Guellec S; Heuzé-Vourc'h N Br J Pharmacol; 2021 Sep; 178(18):3829-3842. PubMed ID: 33974271 [TBL] [Abstract][Full Text] [Related]
19. Temperate Bacteriophages from Chronic Pseudomonas aeruginosa Lung Infections Show Disease-Specific Changes in Host Range and Modulate Antimicrobial Susceptibility. Tariq MA; Everest FLC; Cowley LA; Wright R; Holt GS; Ingram H; Duignan LAM; Nelson A; Lanyon CV; Perry A; Perry JD; Bourke S; Brockhurst MA; Bridge SH; De Soyza A; Smith DL mSystems; 2019 Jun; 4(4):. PubMed ID: 31164451 [TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of lytic bacteriophages against Majdani R; Shams Ghahfarokhi E Iran J Microbiol; 2022 Apr; 14(2):203-213. PubMed ID: 35765555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]